➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Johnson and Johnson
Harvard Business School
Mallinckrodt
Moodys

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Sildenafil Citrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00123162 Viagra in the Treatment of Primary Dysmenorrhea Completed National Institutes of Health (NIH) Phase 1/Phase 2 2007-05-01 The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.
NCT00123162 Viagra in the Treatment of Primary Dysmenorrhea Completed Milton S. Hershey Medical Center Phase 1/Phase 2 2007-05-01 The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.
NCT00141310 Sildenafil Citrate for the Treatment of Established Pre-Eclampsia Terminated Pfizer Phase 2 2004-09-01 To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia
NCT00142506 Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer Completed Beth Israel Medical Center Phase 3 2005-02-01 Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506 Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer Completed Icahn School of Medicine at Mount Sinai Phase 3 2005-02-01 Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506 Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer Completed St. Luke's-Roosevelt Hospital Center Phase 3 2005-02-01 Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506 Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer Completed Memorial Sloan Kettering Cancer Center Phase 3 2005-02-01 Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sildenafil Citrate

Condition Name

Condition Name for Sildenafil Citrate
Intervention Trials
Erectile Dysfunction 17
Impotence 11
Pulmonary Arterial Hypertension 7
Pulmonary Hypertension 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sildenafil Citrate
Intervention Trials
Erectile Dysfunction 29
Hypertension 17
Hypertension, Pulmonary 11
Familial Primary Pulmonary Hypertension 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sildenafil Citrate

Trials by Country

Trials by Country for Sildenafil Citrate
Location Trials
United States 150
United Kingdom 33
Egypt 15
Japan 13
Brazil 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sildenafil Citrate
Location Trials
Texas 11
California 10
Massachusetts 9
North Carolina 8
New York 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sildenafil Citrate

Clinical Trial Phase

Clinical Trial Phase for Sildenafil Citrate
Clinical Trial Phase Trials
Phase 4 30
Phase 3 20
Phase 2/Phase 3 5
[disabled in preview] 55
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sildenafil Citrate
Clinical Trial Phase Trials
Completed 58
Recruiting 19
Not yet recruiting 14
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sildenafil Citrate

Sponsor Name

Sponsor Name for Sildenafil Citrate
Sponsor Trials
Pfizer 35
Ain Shams University 7
Assiut University 4
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sildenafil Citrate
Sponsor Trials
Other 89
Industry 48
NIH 5
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Colorcon
Moodys
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.